Philip Morris International Inc. (NYSE: PM) today released a new white paper, “Human Cognition: The Next Frontier?”, inviting leaders across business, policy, and academia to join a global convers...

The paper calls for global debate to ensure AI enhances-rather than diminishes-uniquely human strengths in an increasingly automated world
STAMFORD, CT: Philip Morris International Inc. (NYSE: PM) today released a new white paper, “Human Cognition: The Next Frontier?”, inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy.
The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the “superskill” of the future, driving progress in an era of human-machine collaboration. As AI automates routine tasks and augments knowledge work, PMI argues that nurturing and protecting cognitive capacity will be essential for organizations seeking to remain resilient and relevant. Where once technology often automated labor-intensive jobs in the quest to improve productivity, now, as intelligent systems take on more cognitive work, organizations must rethink how they develop and protect the human mind itself.
“In our strategic shift toward a smoke-free future, we learned that technology helps us move faster - but real progress depends on people. Change isn’t just about scientific and technological advances; it’s about vision, ambition, and how people apply innovations. A decade ago, we were a cigarette company, and now our smoke-free products are available in 100 markets and account for 41% of our net revenuesi,” said Moira Gilchrist, Chief Global Communications Officer, PMI. “That journey was powered by curiosity, creativity, and the courage to challenge assumptions. If we treat cognition like the scarce resource that it is and use AI to enhance – not replace – human strengths, organizations will make better decisions, and society will be more resilient in the AI era.”
The white paper highlights the need to protect human cognition in the era of AI, outlining a set of accelerating cognitive risks that will shape whether society benefits from AI or becomes overwhelmed by it:
PMI’s commitment to fostering dialogue on these issues reflects the reality that today it is a changed company, as the company pursues a vision of a smoke-free future and invests in continuous learning and new capabilities for its workforce, aiming to be predominantly smoke-free by 2030.
Philip Morris International: A Global Smoke-Free Champion
Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 100 markets, and as of June 30, 2025 PMI estimates they were used by over 41 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41% of PMI’s first-nine months 2025 total net revenues. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness and healthcare areas and aims to enhance life through the delivery of seamless health experiences. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.
i As of September 30, 2025.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Advocacy, the AI-native, context-first litigation workspace, today emerged from stealth and announced it has raised $3.5 million in seed funding. The…
Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, today announced the appointment of Greta Van…
Please replace the release dated March 3, 2026 with the following corrected version due to multiple revisions. The updated release reads: ARIA SYSTEMS…
Talk2Me Inc., the licensed celebrity digital twin platform, today announced the official launch of the Kelsey Plum Talk2Me Twin – an always-on, AI-powered…